Blog

Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.

Photo of Guilherme Perini taken from X/Twitter

Oct 3, 2023, 18:07

Guilherme Perini: Would love to hear colleagues from Low- or Middle-Income Countries.

Guilherme Perini, Hematologist at Israelita Albert Einstein Hospital, shared a post by Bishal Gyawali on X/Twitter:

“Do any of the authors actually practice in Low- or Middle-Income Countries? No. I would gladly have as many trials as possible if I could get my patients new and better drugs. But maybe that’s just me. Would love to hear from my colleagues from Low- or Middle-Income Countries.”

Quoting Bishal Gyawali, Medical Oncologist at Queen’s University’s post:

Our new editorial is out today in BMJ Oncology on the globalization of cancer drug trials. Thanks, Kristina Jenei for leading this, and Fabio Moraes for the collaboration.”

For details click here.
Source: Guilherme Perini/Twitter and Bishal Gyawali/Twitter

Bishal Gyawali BMJ Oncology cancer Fabio Moraes Guilherme Perini Israelita Albert Einstein Hospital Kristina Jenei OncoDaily Oncology Queen’s University

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage